Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Abbreviated Breast MRI Effective for High-Risk Screening without Compromising Diagnostic Accuracy

By HospiMedica International staff writers
Posted on 11 Mar 2024

Two recent studies have revealed the effectiveness and utility of abbreviated breast MRI, not only for screening high-risk women but also in assessing "pure" ductal carcinoma in situ (DCIS). More...

Abbreviated breast MRI emerges as a cost-effective solution, maintaining diagnostic precision while offering a shorter and safer alternative to traditional, lengthier breast MRI screenings, also facilitating smoother operations in radiology departments.

In the first study, researchers at St. Bartholomew's Hospital (London, UK) examined the performance of abbreviated breast MRI in a high-risk group for breast cancer. This study, incorporating 236 abbreviated MRI exams from 2018 to 2021, featured a six-sequence exam protocol - including precontrast T1W, T2W axial, two dynamic postcontrast, subtracted axial sequences, and MIP reconstruction - in contrast to the conventional 19-sequence approach. Four blind readers, unaware of patients’ previous imaging, history, and outcomes, analyzed the scans. The abbreviated exams identified four invasive cancers and one BI-RADS 3 lesion.

Key findings indicated that the abbreviated MRI protocol was effective in terms of negative predictive value and sensitivity. Furthermore, the average reading time for these exams was approximately 69 seconds. Agreement between the abbreviated and full protocols was high at 91.5%, although the shorter protocol had a slightly increased recall rate (9.5%) compared to the full protocol (6.1%). The study concluded that while abbreviated breast MRI showed lower positive predictive value and sensitivity compared to the full protocol, it remained a viable option for screening women at high risk of breast cancer.

In the second study, researchers at Istanbul University (Istanbul, Turkey) focused on the detection of pure DCIS using a shortened MRI protocol. Involving 25 pure DCIS cases diagnosed via biopsy and identified on breast MRI between May 2021 and October 2023, the abbreviated protocol comprised T1-weighted imaging without contrast, T1WI with first-minute contrast, and a one-minute subtraction image, reviewed by two radiologists. This approach demonstrated 80% specificity in identifying pure DCIS, confirming that such lesions can be detected effectively with an abbreviated MRI protocol.

Related Links:
St. Bartholomew's Hospital
Istanbul University


Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Ultrasound System
FUTUS LE
External Defibrillator
HeartSave Y | YA
Infant Resuscitator
Easypuff
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.